BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1136 related articles for article (PubMed ID: 24137945)

  • 21. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts.
    Blau O; Baldus CD; Hofmann WK; Thiel G; Nolte F; Burmeister T; Türkmen S; Benlasfer O; Schümann E; Sindram A; Molkentin M; Mundlos S; Keilholz U; Thiel E; Blau IW
    Blood; 2011 Nov; 118(20):5583-92. PubMed ID: 21948175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial.
    Braulke F; Schulz X; Germing U; Schuler E; Platzbecker U; Nolte F; Hofmann WK; Giagounidis A; Götze K; Lübbert M; Schlenk RF; Schanz J; Bacher U; Ganser A; Büsche G; Letsch A; Schafhausen P; Bug G; Brümmendorf TH; Haas R; Trümper L; Shirneshan K; Haase D
    Ann Hematol; 2017 Jun; 96(6):887-894. PubMed ID: 28374162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reserves, functional, immunoregulatory, and cytogenetic properties of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes.
    Klaus M; Stavroulaki E; Kastrinaki MC; Fragioudaki P; Giannikou K; Psyllaki M; Pontikoglou C; Tsoukatou D; Mamalaki C; Papadaki HA
    Stem Cells Dev; 2010 Jul; 19(7):1043-54. PubMed ID: 19788374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia.
    van Lom K; Hagemeijer A; Vandekerckhove F; Smit EM; Löwenberg B
    Br J Haematol; 1996 Jun; 93(3):594-600. PubMed ID: 8652379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome.
    Lopez-Villar O; Garcia JL; Sanchez-Guijo FM; Robledo C; Villaron EM; Hernández-Campo P; Lopez-Holgado N; Diez-Campelo M; Barbado MV; Perez-Simon JA; Hernández-Rivas JM; San-Miguel JF; del Cañizo MC
    Leukemia; 2009 Apr; 23(4):664-72. PubMed ID: 19151777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
    Saitoh K; Miura I; Takahashi N; Miura AB
    Blood; 1998 Oct; 92(8):2886-92. PubMed ID: 9763574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities.
    López-Holgado N; Arroyo JL; Pata C; Villarón E; Sánchez Guijo F; Martín A; Hernández Rivas JM; Orfao A; San Miguel JF; Del Cañizo Fernández-Roldán MC
    Leuk Res; 2004 Nov; 28(11):1181-7. PubMed ID: 15380343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS).
    Mohamedali AM; Gäken J; Ahmed M; Malik F; Smith AE; Best S; Mian S; Gaymes T; Ireland R; Kulasekararaj AG; Mufti GJ
    Leukemia; 2015 Sep; 29(9):1928-38. PubMed ID: 25943179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perturbed hematopoietic stem and progenitor cell hierarchy in myelodysplastic syndromes patients with monosomy 7 as the sole cytogenetic abnormality.
    Dimitriou M; Woll PS; Mortera-Blanco T; Karimi M; Wedge DC; Doolittle H; Douagi I; Papaemmanuil E; Jacobsen SE; Hellström-Lindberg E
    Oncotarget; 2016 Nov; 7(45):72685-72698. PubMed ID: 27683035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
    Sokolic RA; Ferguson W; Mark HF
    Cancer Genet Cytogenet; 1999 Dec; 115(2):106-13. PubMed ID: 10598142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand.
    Phrommin S; Tantiworawit A; Rattanathammethee T; Puaninta C; Pangjaidee N; Aungsuchawan S; Bumroongkit K
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):639-645. PubMed ID: 32212788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry.
    Kanter-Lewensohn L; Hellström-Lindberg E; Kock Y; Elmhorn-Rosenborg A; Ost A
    Eur J Haematol; 1996 Mar; 56(3):124-9. PubMed ID: 8598230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the role of fluorescence in situ hybridization in cytogenetic evaluation of myelodysplastic syndrome].
    Qu SQ; Xu ZF; Li CW; Liu XP; Qin TJ; Zhang Y; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):839-42. PubMed ID: 23384907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elderly patients.
    Rossi G; Pelizzari AM; Bellotti D; Tonelli M; Barlati S
    Leukemia; 2000 Apr; 14(4):636-41. PubMed ID: 10764149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
    Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
    Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis on laboratory and clinical characteristics in 65 cases of myelodysplastic syndrome].
    Chen BA; Gao C; Ding J; Ding JH; Sun YY; Zhao G; Cheng J; Wang J; Bao W; Song HH; Xia GH; Ma JL; Wu LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1472-6. PubMed ID: 20030929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preliminary study of biological characteristics of myelodysplastic syndromes clonal cells].
    Li X; Wu LY; Ying SX; Chang CK; He Q; Song LQ; Pu Q
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):478-83. PubMed ID: 18072633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
    Gao DG; Li BT; Zhou LN; Chen H; Zhang B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.